San Antonio, TX, December 9, 2025
The Icahn School of Medicine at Mount Sinai will present groundbreaking breast cancer research at the upcoming San Antonio Breast Cancer Symposium (SABCS). Running from December 9-12, the symposium offers a crucial platform for experts to share advancements in prevention, diagnosis, and treatment. Key presentations include innovative predictive models and novel therapeutic strategies for challenging forms of breast cancer, aiming to improve outcomes for patients worldwide.
San Antonio, TX – The Icahn School of Medicine at Mount Sinai is set to showcase groundbreaking research in breast cancer at the 2025 San Antonio Breast Cancer Symposium (SABCS) from December 9-12. This important event, held at the Henry B. González Convention Center, is a vital platform for researchers and clinicians to share innovations and findings that could shape the future of breast cancer care.
SABCS has long been recognized as a leading conference dedicated to the exploration of breast cancer biology, clinical advances, and patient outcomes. It draws experts from around the globe who come together to highlight significant insights that promise to illuminate strategies for prevention, diagnosis, and treatment of breast cancer.
Key Presentations from Mount Sinai
Oral Session: Advanced Predictive Models
Dr. Joseph Sparano will lead a pivotal session on December 10, focusing on “Multimodal Artificial Intelligence Models for Predicting Breast Cancer Recurrence in TAILORx.” His research is particularly promising as it integrates image, clinical, and molecular data, offering new hope in predicting both early and late breast cancer recurrences, a critical need in effective patient management.
Poster Sessions: Innovative Approaches Unveiled
Throughout the symposium, several poster presentations will take center stage:
– Dr. Hanna Irie will delve into novel therapeutic strategies aimed at addressing brain metastases in triple-negative breast cancer, an area needing urgent advancements due to its challenging nature.
– Dr. Justine M. Anderson will present two studies, the first examining the tolerability of the KEYNOTE-522 regimen within a diverse real-world population. The second will provide insights into pathologic complete response rates following the same regimen, highlighting efforts toward optimizing treatment efficacy.
– Dr. Prathyusha Pandu will also share findings on the tolerability of combining adjuvant therapies for early-stage triple-negative breast cancer, showcasing the importance of adapting treatment to different patient needs.
Field-Defining Presentations
Dr. Rima Patel will discuss the safety and efficacy of a combined neoadjuvant treatment for older adults with early triple-negative breast cancer, addressing an often-overlooked demographic in clinical trials. Additionally, Dr. Patel will share insights into the feasibility of clinical nurse-initiated geriatric assessments in oncology clinics, signifying a shift toward holistic treatment approaches.
The Importance of SABCS for San Antonio
Hosting the SABCS is a significant achievement for San Antonio, showcasing the city’s role as a hub for medical research and innovation. The gathering not only brings invaluable knowledge to local healthcare providers but also emphasizes the community’s commitment to improving cancer care. Such events illustrate the power of private-public partnerships and demonstrate how fostering an environment conducive to medical advancements can benefit local patients significantly.
The ability to streamline coordination efforts and reduce unnecessary bureaucracy can lead to improved engagement and participation in similar events, ultimately paving the way for greater community involvement and better health outcomes.
Conclusion: Embrace the Future of Breast Cancer Care
The 2025 San Antonio Breast Cancer Symposium represents an extraordinary opportunity for collaboration and innovation in breast cancer research. With prominent experts gathering to share their findings, the implications for patient care and treatment protocols are substantial. Attendees are encouraged to participate actively, ensuring the insights gained from this symposium can translate into better outcomes for all those affected by breast cancer in the community.
Stay engaged with the local events and initiatives that foster community growth, and be part of the movement towards improved healthcare solutions in San Antonio, TX.
FAQ
What is the San Antonio Breast Cancer Symposium (SABCS)?
SABCS is a leading conference dedicated to breast cancer research and clinical advances, bringing together global experts to highlight the latest insights shaping future care.
When and where is SABCS 2025 being held?
SABCS 2025 is being held from December 9-12, 2025, at the Henry B. González Convention Center, 900 E. Market Street, San Antonio, Texas.
What are some of the key presentations by Mount Sinai at SABCS 2025?
- Oral Session: Dr. Joseph Sparano will present on integrating image, clinical, and molecular data to predict early and late breast cancer recurrence in TAILORx. This session is scheduled for Wednesday, December 10, from 9:30 am to noon CST.
- Poster Sessions:
- Dr. Hanna Irie will discuss novel therapeutic targeting of triple-negative breast cancer brain metastases.
- Dr. Justine M. Anderson will present on the tolerability of the KEYNOTE-522 regimen in a diverse real-world cohort of patients with early triple-negative breast cancer.
- Dr. Anderson will also share data on evaluating real-world pathologic complete response rates following the KEYNOTE-522 regimen at an urban center.
- Dr. Prathyusha Pandu will present on the tolerability of the combination of adjuvant pembrolizumab and capecitabine in a diverse real-world cohort of patients with early-stage triple-negative breast cancer.
- Presentations:
- Dr. Rima Patel will discuss the safety and efficacy of neoadjuvant cyclophosphamide, methotrexate, fluorouracil (CMF), and pembrolizumab in older adults with early triple-negative breast cancer.
- Dr. Patel will also present on the feasibility of clinical nurse-initiated geriatric assessments in breast medical oncology clinics through a pilot program.
Where can I find more information about the symposium?
For more information about the symposium, including the full scientific program and registration details, visit the official SABCS website.
| Presentation Type | Title | Presenter | Date and Time |
|---|---|---|---|
| Oral Session | Multimodal Artificial Intelligence Models for Predicting Breast Cancer Recurrence in TAILORx | Dr. Joseph Sparano | Wednesday, December 10, 9:30 am – noon CST |
| Poster Sessions | Novel Therapeutic Targeting Triple-Negative Breast Cancer Brain Metastases | Dr. Hanna Irie | To be announced |
| Tolerability of the KEYNOTE-522 Regimen in a Diverse Real-World Cohort | Dr. Justine M. Anderson | To be announced | |
| Evaluating Real-World Pathologic Complete Response Rates Following the KEYNOTE-522 Regimen | Dr. Justine M. Anderson | To be announced | |
| Tolerability of Adjuvant Pembrolizumab and Capecitabine Combination in Early-Stage Triple-Negative Breast Cancer | Dr. Prathyusha Pandu | To be announced | |
| Presentations | Safety and Efficacy of Neoadjuvant Cyclophosphamide, Methotrexate, Fluorouracil (CMF), and Pembrolizumab in Older Adults with Early Triple-Negative Breast Cancer | Dr. Rima Patel | To be announced |
Deeper Dive: News & Info About This Topic
HERE Resources
Innovative Research on Breast Cancer at San Antonio Symposium
2025 San Antonio Breast Cancer Symposium to Showcase Groundbreaking Research
Intensity Therapeutics Presenting at San Antonio Breast Cancer Symposium
Plus Therapeutics to Present Groundbreaking Research at SABCS
Plus Therapeutics to Present Breakthrough Study on Cancer Treatment
Classic Collision Acquires Fawbush Body Shop in Livingston
ESMO 2025 Announces Key Events and Speakers
San Antonio Set to Welcome New Multispecialty and Research Hospital
San Antonio University Tackles Rising Cancer Rates in Latino Community
Author: STAFF HERE SAN ANTONIO WRITER
The SAN ANTONIO STAFF WRITER represents the experienced team at HERESanAntonio.com, your go-to source for actionable local news and information in San Antonio, Bexar County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Fiesta San Antonio, San Antonio Stock Show & Rodeo, and Dia de los Muertos. Our coverage extends to key organizations like the Greater San Antonio Chamber of Commerce and United Way of San Antonio and Bexar County, plus leading businesses in retail, insurance, and energy that power the local economy such as H-E-B, USAA, and Valero Energy. As part of the broader HERE network, including HEREAustinTX.com, HERECollegeStation.com, HEREDallas.com, and HEREHouston.com, we provide comprehensive, credible insights into Texas's dynamic landscape.
